<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20220520054932N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2022-05-27</date_registration>
      <primary_sponsor>The University of Faisalabad</primary_sponsor>
      <public_title>EFFECT OF MULLIGAN’S PAIN RELEASE PHENOMENON ALONG WITH KINESIOTAPING IN PATELLOFEMORAL PAIN SYNDROME</public_title>
      <acronym></acronym>
      <scientific_title>EFFECT OF MULLIGAN’S PAIN RELEASE PHENOMENON ALONG WITH KINESIOTAPING IN PATELLOFEMORAL PAIN SYNDROME</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2022-03-20</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>40</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/63774</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Single blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: patients that fulfill the inclusion criteria will be randomly divided into experimental and active control group by using the lottery method, Blinding description: participant is blinded means they do not know what treatment the other group gets.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Patellofemoral pain syndrome.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: 1,  this group will receive Mulligan's pain release phenomenon and baseline treatment(kinesiotaping, strengthening of vastus medialis oblique muscle and Ultrasonic) in12 sessions for 4 weeks with alternate days. compression PRP will be provided by compressing patella against condyles of femur then knee joint will be moved in flexion and extension while maintaining the compression for 15 seconds. visual analogue scale and Anterior Knee Pain scale will be used to get reading before and after the completion of treatment sessions. Intervention 2: Active Control group: Group B will be given Baseline treatment which includes Kinesiotaping of patellofemoral joint and  strengthening of Vastus medialis Oblique muscle and Ultrasonic.  in12 sessions for 4 weeks with alternate days.visual analogue scale and Anterior Knee Pain scale will be used to get reading before and after the completion of treatment sessions.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
IPD collected for primary and secondary outcome measures

When:
Jan 2023

To whom:
people working in any domain can be authorized to get this data

Conditions:
Any wrong information or editional errors

Where to obtain:
this data is only available on-demand via email mention to the person responsible

How to obtain:
documents can also be processed via university emails

Comments:
Data is private legacy respect it</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Dr Sidra Majeed</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>house #560, Mohalla sheikh lahory</address>
        <city>Jhang Sadar</city>
        <country1>Pakistan</country1>
        <zip>35200</zip>
        <telephone>+92 309 1106072</telephone>
        <email>hafizakinzashakoor567@yahoo.com</email>
        <affiliation>The University of Faisalabad</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Dr Sidra Majeed</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>House # 560, Mohalla sheikh lahory</address>
        <city>Jhang Sadar</city>
        <country1>Pakistan</country1>
        <zip>35200</zip>
        <telephone>+92 309 1106072</telephone>
        <email>hafizakinzashakoor567@yahoo.com</email>
        <affiliation>The University of Faisalabad</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Pakistan</country2>
    </countries>
    <criteria>
      <inclusion_criteria>•	18-40 years adults having PFP for more than three months
•	PFP bring forth during clinical examination (patellar grind test, apprehension test)
•	PFP in at least two functional activities (sitting for long time, stairs climbing, running, squatting, kneeling and jumping)
•	Both male &amp; female
•	Patients with moderate pain ranging from 3 to 7</inclusion_criteria>
      <agemin>18 years</agemin>
      <agemax>40 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>•	Any lower limb surgery in past 6 months
•	History of dislocation or subluxation of patella in past 6 months
•	Allergy from taping
•	Chronic illness that may limit training
•	Knee osteoarthritis (patellofemoral and tibiofemoral joint)
•	Chondromalacia patellae
•	Pes anserine bursitis (2)</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code></hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword></hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Rehabilitation</i_code>
      <i_code>Rehabilitation</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: 1,  this group will receive Mulligan's pain release phenomenon and baseline treatment(kinesiotaping, strengthening of vastus medialis oblique muscle and Ultrasonic) in12 sessions for 4 weeks with alternate days. compression PRP will be provided by compressing patella against condyles of femur then knee joint will be moved in flexion and extension while maintaining the compression for 15 seconds. visual analogue scale and Anterior Knee Pain scale will be used to get reading before and after the completion of treatment sessions</i_keyword>
      <i_keyword>Active Control group: Group B will be given Baseline treatment which includes Kinesiotaping of patellofemoral joint and  strengthening of Vastus medialis Oblique muscle and Ultrasonic.  in12 sessions for 4 weeks with alternate days.visual analogue scale and Anterior Knee Pain scale will be used to get reading before and after the completion of treatment sessions</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Pain. Timepoint: total 4 weeks of interventional period with alternate days contain 12 sessions. visual analogue scale will be used before and after completion of treatment session. Method of measurement: visual analogue scale.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Anterior knee pain. Timepoint: total 4 weeks of interventional period with alternate days contain 12 sessions. Anterior Knee Pain scale will be used before and after completion of treatment session. Method of measurement: Anterior Knee Pain scale.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>The University of Faisalabad</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2022-03-13</approval_date>
        <contact_name>Ethics committee of the university of Faisalabad</contact_name>
        <contact_address>house#560,Mohalla sheikh lahory Jhang Sadar Punjab Pakistan</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
